|
US1001159A
(en)
|
1910-07-25 |
1911-08-22 |
Elizabeth Nielsen |
Skirt-gage.
|
|
GB1472257A
(en)
|
1973-09-10 |
1977-05-04 |
Christiaens Sa A |
Derivative of 4-hydroxy-5-azacoumarin
|
|
US4866182A
(en)
|
1988-02-18 |
1989-09-12 |
Merrell Dow Pharmaceuticals Inc. |
Cardiotonic alkanoyl and aroyl oxazolones
|
|
US5338740A
(en)
|
1993-07-13 |
1994-08-16 |
Pfizer Inc. |
Angiotensin II receptor antagonists
|
|
JP3795305B2
(ja)
|
1999-07-19 |
2006-07-12 |
田辺製薬株式会社 |
医薬組成物
|
|
PL369598A1
(en)
|
2001-02-21 |
2005-05-02 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
EE200300469A
(et)
|
2001-03-28 |
2004-02-16 |
Pfizer Inc. |
N-fenpropüültsüklopentüülasendatud glutaramiidi derivaadid kui NEP inhibiitorid FSAD puhul
|
|
EP1424336A4
(en)
|
2001-09-03 |
2004-11-10 |
Takeda Chemical Industries Ltd |
1,3-BENZOTHIAZINE DERIVATIVES AND THEIR USE
|
|
JP2005162612A
(ja)
|
2002-01-09 |
2005-06-23 |
Ajinomoto Co Inc |
アシルスルホンアミド誘導体
|
|
JP2005170790A
(ja)
|
2002-01-09 |
2005-06-30 |
Ajinomoto Co Inc |
Ｎ−アルキルスルフォニル置換アミド誘導体
|
|
AP1822A
(en)
*
|
2002-02-14 |
2008-01-30 |
Pharmacia Corp |
Substituted pyridinones as modulators of P38 MAP kinase.
|
|
US20040147561A1
(en)
*
|
2002-12-27 |
2004-07-29 |
Wenge Zhong |
Pyrid-2-one derivatives and methods of use
|
|
US20090048301A1
(en)
|
2003-07-09 |
2009-02-19 |
Imclone Systems Incorporated |
Heterocyclic compounds and their use as anticancer agents
|
|
US20060004001A1
(en)
|
2004-02-27 |
2006-01-05 |
Merz Pharma Gmbh & Co., Kgaa |
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
|
|
PE20060285A1
(es)
*
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
|
CA2561628C
(en)
|
2004-04-01 |
2012-05-08 |
Eli Lilly And Company |
Histamine h3 receptor agents, preparation and therapeutic uses
|
|
KR101195801B1
(ko)
|
2004-06-18 |
2012-11-05 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
Ｘａ 인자 억제제
|
|
DK1786790T3
(da)
|
2004-07-26 |
2009-07-20 |
Lilly Co Eli |
Oxazolderivater som histamin H3 receptorstoffer, fremstilling og terapeutiske anvendelser
|
|
EP1655283A1
(en)
|
2004-11-08 |
2006-05-10 |
Evotec OAI AG |
11beta-HSD1 Inhibitors
|
|
WO2006123165A2
(en)
*
|
2005-05-19 |
2006-11-23 |
Astex Therapeutics Limited |
Pyrimidine derivatives as hsp90 inhibitors
|
|
WO2007023242A1
(en)
|
2005-08-24 |
2007-03-01 |
Merz Pharma Gmbh & Co. Kgaa |
Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
|
|
EA018128B1
(ru)
|
2006-01-23 |
2013-05-30 |
Амген Инк. |
Модуляторы аурора киназы, способы их получения и их применение
|
|
JP2007314516A
(ja)
|
2006-04-25 |
2007-12-06 |
Daiichi Sankyo Co Ltd |
２以上の置換基を有するベンゼン化合物を含有する医薬
|
|
CN101522623B
(zh)
|
2006-08-03 |
2013-06-12 |
塔夫茨大学信托人 |
无潮红烟酸类似物和其使用方法
|
|
JP2009545630A
(ja)
|
2006-08-04 |
2009-12-24 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
化合物
|
|
EP1894924A1
(en)
|
2006-08-29 |
2008-03-05 |
Phenex Pharmaceuticals AG |
Heterocyclic FXR binding compounds
|
|
US20100035860A1
(en)
|
2006-12-01 |
2010-02-11 |
Jey Raju Jeyaseelan |
Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy
|
|
EP2142546B1
(en)
|
2007-03-28 |
2017-06-07 |
Saniona A/S |
Purinyl derivatives and their use as potassium channel modulators
|
|
CN103351390A
(zh)
*
|
2007-11-21 |
2013-10-16 |
解码遗传Ehf公司 |
用于治疗肺部和心血管病症的联芳基pde4 抑制剂
|
|
US20110034378A1
(en)
|
2008-01-25 |
2011-02-10 |
Chaitanya Dutt |
Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc.
|
|
AU2009233711B2
(en)
|
2008-04-09 |
2015-02-12 |
Infinity Pharmaceuticals, Inc |
Inhibitors of fatty acid amide hydrolase
|
|
AU2009253046A1
(en)
|
2008-05-30 |
2009-12-03 |
Foster Wheeler Energia Oy |
Method of and system for generating power by oxyfuel combustion
|
|
CN102137866A
(zh)
|
2008-06-30 |
2011-07-27 |
赛林药物股份有限公司 |
羟吲哚化合物
|
|
JP5535931B2
(ja)
|
2008-10-27 |
2014-07-02 |
武田薬品工業株式会社 |
二環性化合物
|
|
RU2011122482A
(ru)
*
|
2008-11-04 |
2012-12-20 |
Энкер Терапьютикс, Инк. |
Apj-рецепторы соединения
|
|
BR112012006630A2
(pt)
|
2009-09-24 |
2016-05-03 |
Hoffmann La Roche |
derivados em indol como moduladores dos canais de cálcio ativados para liberação de cálcio (crac)
|
|
CN102510864A
(zh)
|
2009-09-24 |
2012-06-20 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒杂环化合物
|
|
US8609663B2
(en)
|
2009-11-18 |
2013-12-17 |
University Of Massachusetts |
Compounds for modulating TLR2
|
|
US8609866B2
(en)
|
2009-12-18 |
2013-12-17 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
CN102241621A
(zh)
|
2010-05-11 |
2011-11-16 |
江苏恒瑞医药股份有限公司 |
5,5-双取代-2-亚氨基吡咯烷类衍生物、其制备方法及其在医药上的应用
|
|
WO2011148956A1
(ja)
|
2010-05-24 |
2011-12-01 |
トーアエイヨー株式会社 |
縮合イミダゾール誘導体
|
|
WO2012040532A1
(en)
*
|
2010-09-24 |
2012-03-29 |
Bristol-Myers Squibb Company |
Substituted oxadiazole compounds and their use as s1p1 agonists
|
|
WO2012074022A1
(ja)
|
2010-12-01 |
2012-06-07 |
旭硝子株式会社 |
イリジウムカチオン錯体および発光組成物
|
|
CA2831978A1
(en)
|
2011-03-03 |
2012-09-07 |
Universitat Des Saarlandes |
Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors
|
|
EP2697196A1
(en)
|
2011-04-13 |
2014-02-19 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
JP6130827B2
(ja)
|
2011-05-17 |
2017-05-17 |
塩野義製薬株式会社 |
ヘテロ環化合物
|
|
US9732051B2
(en)
|
2011-12-23 |
2017-08-15 |
Basf Se |
Isothiazoline compounds for combating invertebrate pests
|
|
EP2844655A1
(en)
|
2012-05-02 |
2015-03-11 |
Lupin Limited |
Substituted pyridine compounds as crac modulators
|
|
BR112014027133A2
(pt)
|
2012-05-09 |
2017-06-27 |
Basf Se |
compostos, composição agrícola ou veterinária, método para o controle das pragas de invertebrados, material de propagação dos vegetais e método para o tratamento ou proteção de um animal.
|
|
PT2858975T
(pt)
|
2012-06-08 |
2019-07-16 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Inibidores de fbxo3
|
|
US20160008339A1
(en)
|
2012-07-02 |
2016-01-14 |
Max-Delbruck-Centrum Fur Molekulare Medizin |
Psoralen derivatives for preventing or treating heart failure or cardiac hypertrophy
|
|
CN103570625A
(zh)
|
2012-07-19 |
2014-02-12 |
南京英派药业有限公司 |
N-(3-杂芳基芳基)-4-芳基芳基甲酰胺和类似物作为Hedgehog通路抑制剂及其应用
|
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
LT2897939T
(lt)
*
|
2012-09-21 |
2017-05-10 |
Sanofi |
Benzimidazolo karboksirūgšties amido dariniai metabolinių arba širdies ir kraujagyslių ligų gydymui
|
|
WO2014062938A1
(en)
|
2012-10-19 |
2014-04-24 |
Bristol-Myers Squibb Company |
Rory modulators
|
|
WO2014144715A1
(en)
|
2013-03-15 |
2014-09-18 |
Memorial Sloan-Kettering Cancer Center |
Hsp90-targeted cardiac imaging and therapy
|
|
US9751881B2
(en)
|
2013-07-31 |
2017-09-05 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
JP6199197B2
(ja)
|
2014-02-07 |
2017-09-20 |
花王株式会社 |
ポリオキシアルキレンアルキルエーテルカルボン酸塩の製造方法
|
|
JP2017071553A
(ja)
|
2014-02-25 |
2017-04-13 |
味の素株式会社 |
ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物
|
|
CR20160433A
(es)
|
2014-03-20 |
2016-12-06 |
Bayer Pharma AG |
Nuevos compuestos
|
|
US9969726B2
(en)
|
2014-06-10 |
2018-05-15 |
Sanford-Burnham Medical Research Institute |
Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof
|
|
MA42145B1
(fr)
|
2015-05-20 |
2020-05-29 |
Amgen Inc |
Triazoles agonistes du récepteur apj
|
|
HRP20191327T1
(hr)
*
|
2015-06-03 |
2019-11-01 |
Bristol Myers Squibb Co |
4-hidroksi-3-(heteroaril)piridin-2-on apj agonisti za primjenju u liječenju kardiovaskularnih poremećaja
|
|
KR101711744B1
(ko)
|
2015-07-16 |
2017-03-02 |
경희대학교 산학협력단 |
옥사디아졸 유도체, 이의 제조방법 및 이를 포함하는 전자수송층
|
|
US10392347B2
(en)
|
2015-10-14 |
2019-08-27 |
Bristol-Myers Squibb Company |
2,4-dihydroxy-nicotinamides as APJ agonists
|
|
US10626096B2
(en)
|
2015-11-24 |
2020-04-21 |
Sanford Burnham Prebys Medical Discovery Institute |
Azole derivatives as apelin receptor agonist
|
|
AR106948A1
(es)
|
2015-12-04 |
2018-03-07 |
Bristol Myers Squibb Co |
Agonistas del receptor de apelina y método de uso
|
|
AU2016366310C1
(en)
|
2015-12-09 |
2021-09-09 |
Research Triangle Institute |
Improved apelin receptor (APJ) agonists and uses thereof
|
|
EP3390400B1
(en)
|
2015-12-16 |
2021-01-20 |
Bristol-Myers Squibb Company |
Heteroarylhydroxypyrimidinones as agonists of the apj receptor
|
|
MY189454A
(en)
|
2016-03-24 |
2022-02-14 |
Bristol Myers Squibb Co |
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
|
|
WO2017218633A1
(en)
|
2016-06-14 |
2017-12-21 |
Bristol-Myers Squibb Company |
6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1h)-one as apj agonists
|
|
KR102521955B1
(ko)
|
2016-06-14 |
2023-04-13 |
브리스톨-마이어스 스큅 컴퍼니 |
Apj 수용체 효능제로서의 4-히드록시-3-술포닐피리딘-2(1h)-온
|
|
KR102521956B1
(ko)
|
2016-10-14 |
2023-04-14 |
브리스톨-마이어스 스큅 컴퍼니 |
3-술포닐-5-아미노피리딘-2,4-디올 apj 효능제
|